Connect, learn and grow. Your journey in our Pharma & Life Sciences Community starts here!
AI in Motion is Trueblue's project born with the aim of creating a continuous movement of sharing and delving deeper into the experiences and real cases of AI applications in Pharma and Life Sciences industries.
The project kicked off at the end of 2021 with “AI Makes Sense!”, where we challenged the common mindset and raised awareness about the many ways in which AI actually "makes sense”.
After lifting this "Maya Veil" it’s time to take it one step further. AI is not just a technology, it can be a Movement, a Reason Why, an Emotion.
This is how “AI in Motion" was born, with a new Video Podcast season, Events and, above all, an exclusive Community to start new AI Stories in Pharma & Life Sciences companies.
Enhance your knowledge
To enhance your knowledge regarding AI relevant information and news to always stay up-to-date with what happens in the market
Dedicated content
To gain access to a wide range of exclusive and dedicated content related to AI in Pharma & Life Sciences
Expand your network
To seize the opportunity to expand your professional network
Compare experiences
To have a space for comparing and sharing experiences and, why not, get/give answers to doubts and concerns
In the video above you can see a glimpse of our Community! However, the most important way to become an "AIMember" is the willingness to become a part of a community made by Humans and leveraged by Artificial Intelligence.
Join us and start this journey together.
Our events
The AI Emotion to be together LIVE!
We give voice to people
who believe in AI's value
When it comes to Artificial Intelligence, there is a fear that Human Intelligence may be replaced by AI. We are embarking on an extraordinary journey of Change Management, and what makes me proudest is the fact that today, people who use MyAiDEA find it an extraordinary tool for amplifying and maximizing performance.
Agile was born from Software. Collaboration among multiple partners is crucial. In my opinion, if we could truly achieve what we envision in this three-way partnership with Trueblue, ourselves, and Microsoft, the result would be something that not only benefits Gedeon Richter but also greatly assists in understanding and predicting many aspects of the pharmaceutical industry that we struggle to comprehend quickly.
Without the right environment, you cannot introduce a new skill. You need to have trainings and specific valuable projects which not only are shared in the company, but also pose as pilots to demonstrate the value of new potentials. On top of that, they need to be useful and actionable.
Innovating is part of our DNA, and Digital Innovation is now a reality. We are still in the early stages, taking the first steps. We are not at the point we aspire to be yet, but it's a journey that has begun and won't stop.
Having many processes also means many controls, with a vast amount of data being generated from different channels and processes. It is necessary to analyze them in order to determine strategic choices and execute actions with a specific purpose. Today, thanks to technologies like AI, this is possible.
To us MyAiDEA, and the work that Trueblue is doing with us, is exactly what we define as the ecosystem that enables us to implement the industry-specific approach.
It is always essential to work as a team, which is Microsoft's approach. There are those who focus on the solution or product, and then there are those who bring in all the 'know-how’ and market experience to effectively tailor that specific solution to the needs of the individual organization, working together to look ahead.
The whole world of Artificial General Intelligence (AGI) will allow us to not get lost in the work routine, but rather to specialize and evolve in what truly matters and what really comes from the help of Artificial Intelligence. Just as the calculator has spared us from getting lost in calculus, AI will enable us to focus on what truly counts.
When people ask me ‘Which technologies did you use to implement Artificial Intelligence at Merck?', I always answer that AI is a commodity. People and cultural change make the real difference.
AI-based technologies and solutions are game changers in today’s market, in every industry and, especially, in the pharmaceutical one, where data must be organized quickly in a functional way. Companies need to fully understand the opportunities generated by AI-based tools.
Knowledge is About Sharing
